0 results:

• Genesys Capital Wins VC Deal of the Year Award
  Founded in 2015, Montreal-based Inversago Pharma is a leader in the development of next-generation CB1 receptor blocker therapies designed to treat obesity, diabetes, and the complications associated with an array of metabolic disorders. Read More
• Luge Capital Closes CAD $96M to Invest in Emerging Fintech Companies
  Luge Capital today announced the successful closing of $96 million for Luge Capital Fund II, the firm’s second fintech-focused fund. Read More